Vaccin nanoparticulaire muqueux contre la toxoplasmose chronique et congénitale
La toxoplasmose est une anthropozoonose cosmopolite due à un protozoaire parasite intracellulaire obligatoire : Toxoplasma gondii. Cette maladie infectieuse est la plus souvent bénigne chez les personnes immunocompétentes mais revêt un caractère de gravité si l’atteinte concerne les femmes enceintes...
Main Author: | Nguyen, Thi Thanh Loi |
---|---|
Other Authors: | Tours |
Language: | fr |
Published: |
2016
|
Subjects: | |
Online Access: | http://www.theses.fr/2016TOUR3802 |
Similar Items
-
Veterinary vaccines against Toxoplasma gondii
by: Elisabeth A Innes, et al.
Published: (2009-03-01) -
Management of suspected primary Toxoplasma gondii infection in pregnant women in Norway: twenty years of experience of amniocentesis in a low-prevalence population
by: Gry Findal, et al.
Published: (2017-04-01) -
Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: A mini-review
by: Khalid Hajissa, et al.
Published: (2019-06-01) -
Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice
by: Wang Hai-Long, et al.
Published: (2016-01-01) -
Vaccine Design Based on Live Attenuated Cells of Toxoplasma gondii: a Review
by: Kourosh Cheraghipour, et al.
Published: (2017-11-01)